FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing
Susan D. Richman(University of Leeds), Richard Adams(Velindre Cancer Centre)
Cited by 10
Related Papers
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
|Gastroenterology|2020|374
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
|Cancer Cell|2023|246
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|The Lancet. Gastroenterology & hepatology|2019|64
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
|European Journal of Cancer|2018|34
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial
|Journal of Clinical Pathology|2015|26